|
| Patient No. | Age (yrs)/gender | Cause of end-stage organ failure | CDC stage/CD4 count before OLT | Initial HAART after OLT | Start of HAART (days after OLT) | HCV or HBV therapy | Followup (Months) | Causes of death |
|
| 1 | 58/m | HCV | A3/168/L | D4T/ 3TC/ABC | 53 | IFN/RBV | 93 | Kidney failure |
|
| 2 | 37/m | HCV/HBV/HDV | C3/86/L | AZT/3TC/ABC | 2 | IFN/RBV 3,5 months after OLT | 56 | Re-retransplantation for primary graft failure, progressive hepatitis, HCV-positive donor organ, sepsis |
|
| 3 | 36/m | HCV | A3/219/L | 3TC/D4T/EFV | 4 | No HCV therapy | 31 | Secondary graft failure for chemotherapy for Hodgkin’s disease and chronic HCV |
|
| 4 | 41/m | HCV | A2/380/L | TVD/FPV/RTV | 75 | No HCV therapy | 25 | Progressive metastasis of HCC |
|
| 5 | 52/m | HCV | B1 | LPV/EFV | 1 | No HCV therapy | 13 | Progressive sceletal metastasis of HCC, abscess after TACE |
|
| 6 | 48/f | HCV | A1/621/L | AZT/3TC/NLF | 2 | No HCV therapy | 10 | Secondary graft failure for progressive cholestatic hepatitis |
|
| 7 | 45/m | HCV | B2/372/L | ABC/3TC/EFV | 34 | IFN/RBV therapy | 8 | Anastomic leak with massive bleeding, multiorgan failure, sepsis |
|
| 8 | 57/m | HBV | A3/202/L | D4T/ 3TC/ABC | 55 | HBs-Ig/lamivudin | 3 | Intrathoracic hemorrhage after placement of a thoracic drain |
|
| 9 | 49/m | HBV | B3/196/L | AZT/ 3TC | 29 | HBs-Ig/lamivudin | 3 | Thrombosis of A. hepatica, graft failure due to organ rejection, biliary leakage and intra-abdominal abscess, sepsis, multiorgan failure |
|
| 10 | 45/m | HCV | C3/193/L | LPV/SQV | 1 | No HCV therapy | 3 | Pseudomonas sepsis, kidney failure after combined liver kidney transplantation |
|
| 11 | 57/m | HCV | —/622/L | no data | no data | No HCV therapy | 2 | Retransplantation due to primary graft nonfunction and organ rejection, kidney failure |
|
| 12 | 48/m | HCV | B2/210/L | no data | no data | No HCV therapy | 1 | Sepsis, multiorgan failure |
|
| 13 | 33/m | Budd-Chiari-Syndrome | B2/595/L | none | no data | no data | 1 | Sepsis |
|
